Next Article in Journal
Induction of Neuronal Differentiation of Rat Muscle-Derived Stem Cells in Vitro Using Basic Fibroblast Growth Factor and Ethosuximide
Next Article in Special Issue
Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon
Previous Article in Journal
The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin
Previous Article in Special Issue
Abnormal Skeletal Growth in Adolescent Idiopathic Scoliosis Is Associated with Abnormal Quantitative Expression of Melatonin Receptor, MT2
Int. J. Mol. Sci. 2013, 14(4), 6597-6613; doi:10.3390/ijms14046597

Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells

1,2,* , 1,2
, 1,3
, 1,2, 1, 1,2, 1,2
, 1
, 1,2, 1
 and 1
Received: 5 March 2013 / Revised: 18 March 2013 / Accepted: 20 March 2013 / Published: 25 March 2013
(This article belongs to the Special Issue Advances in the Research of Melatonin)
View Full-Text   |   Download PDF [1623 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: It is well established that melatonin exerts antitumoral effects in many cancer types, mostly decreasing cell proliferation at low concentrations. On the other hand, induction of apoptosis by melatonin has been described in the last few years in some particular cancer types. The cytotoxic effect occurs after its administration at high concentrations, and the molecular pathways involved have been only partially determined. Moreover, a synergistic effect has been found in several cancer types when it is administered in combination with chemotherapeutic agents. In the present review, we will summarize published work on the pro-apoptotic effect of melatonin in cancer cells and the reported mechanisms involved in such action. We will also construct a hypothesis on how different cell signaling pathways may relate each other on account for such effect.
Keywords: melatonin; cancer cells; apoptosis; ROS melatonin; cancer cells; apoptosis; ROS
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Rodriguez, C.; Martín, V.; Herrera, F.; García-Santos, G.; Rodriguez-Blanco, J.; Casado-Zapico, S.; Sánchez-Sánchez, A.M.; Suárez, S.; Puente-Moncada, N.; Anítua, M.J.; Antolín, I. Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells. Int. J. Mol. Sci. 2013, 14, 6597-6613.

AMA Style

Rodriguez C, Martín V, Herrera F, García-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Sánchez-Sánchez AM, Suárez S, Puente-Moncada N, Anítua MJ, Antolín I. Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells. International Journal of Molecular Sciences. 2013; 14(4):6597-6613.

Chicago/Turabian Style

Rodriguez, Carmen; Martín, Vanesa; Herrera, Federico; García-Santos, Guillermo; Rodriguez-Blanco, Jezabel; Casado-Zapico, Sara; Sánchez-Sánchez, Ana M.; Suárez, Santos; Puente-Moncada, Noelia; Anítua, María J.; Antolín, Isaac. 2013. "Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells." Int. J. Mol. Sci. 14, no. 4: 6597-6613.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert